129 related articles for article (PubMed ID: 36941225)
1. Venous thromboembolism in metastatic pancreatic cancer.
Laderman L; Sreekrishnanilayam K; Pandey RK; Handorf E; Blumenreich A; Sorice KA; Lynch SM; Cheema K; Nagappan L; Sosa IR; Dotan E; Vijayvergia N
Eur J Haematol; 2023 Jun; 110(6):706-714. PubMed ID: 36941225
[TBL] [Abstract][Full Text] [Related]
2. Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.
Yamai T; Ikezawa K; Hiraga E; Kawamoto Y; Hirao T; Higashi S; Daiku K; Maeda S; Abe Y; Urabe M; Kai Y; Takada R; Nakabori T; Fukutake N; Uehara H; Fujita M; Ohkawa K
PLoS One; 2022; 17(3):e0264653. PubMed ID: 35231078
[TBL] [Abstract][Full Text] [Related]
3. [Venous thromboembolism and pancreatic cancer].
Frère C; Bournet B; Benzidia I; Jamelot M; Debourdeau P; Hij A; Rafii-Elayoubi H; Buscail L; Farge D;
J Med Vasc; 2018 Jul; 43(4):246-254. PubMed ID: 29981733
[TBL] [Abstract][Full Text] [Related]
4. Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.
Barrau M; Maoui K; Le Roy B; Roblin X; Mismetti P; Phelip JM; Williet N
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3447-3454. PubMed ID: 33715087
[TBL] [Abstract][Full Text] [Related]
5. ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.
Godinho J; Casa-Nova M; Moreira-Pinto J; Simões P; Paralta Branco F; Leal-Costa L; Faria A; Lopes F; Teixeira JA; Passos-Coelho JL
Oncologist; 2020 Feb; 25(2):e284-e290. PubMed ID: 32043787
[TBL] [Abstract][Full Text] [Related]
6. Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
Kruger S; Haas M; Burkl C; Goehring P; Kleespies A; Roeder F; Gallmeier E; Ormanns S; Westphalen CB; Heinemann V; Rank A; Boeck S
Thromb Res; 2017 Sep; 157():9-15. PubMed ID: 28675831
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer.
Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ
J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study.
Lee JC; Ro YS; Cho J; Park Y; Lee JH; Hwang JH; Choi HJ; Lee S
Medicine (Baltimore); 2016 Apr; 95(17):e3472. PubMed ID: 27124043
[TBL] [Abstract][Full Text] [Related]
10. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
[TBL] [Abstract][Full Text] [Related]
11. Burden of venous thromboembolism in patients with pancreatic cancer.
Frere C
World J Gastroenterol; 2021 May; 27(19):2325-2340. PubMed ID: 34040325
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
13. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
[TBL] [Abstract][Full Text] [Related]
14. Venous Thromboembolism in Patients with Advanced Pancreatic Cancer Receiving Palliative Chemotherapy: Incidence and Effect on Prognosis.
Jeong HT; Bae JH; Kim HG; Han J
Korean J Gastroenterol; 2023 Mar; 81(3):109-120. PubMed ID: 36960693
[TBL] [Abstract][Full Text] [Related]
15. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.
Guadagni F; Riondino S; Formica V; Del Monte G; Morelli AM; Lucchetti J; Spila A; D'Alessandro R; Della-Morte D; Ferroni P; Roselli M
World J Gastroenterol; 2017 Jul; 23(28):5187-5195. PubMed ID: 28811713
[TBL] [Abstract][Full Text] [Related]
17. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Predictors of Venous Thromboembolism After Robot-Assisted Radical Cystectomy.
Elsayed AS; Ozair S; Iqbal U; Mostowy M; Jing Z; Gibson S; Durrani M; Hussein AA; Guru KA
Urology; 2021 Mar; 149():146-153. PubMed ID: 33221416
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.
Okusaka T; Saiura A; Shimada K; Ikeda M; Ioka T; Kimura T; Hosokawa J; Takita A; Oba MS
J Gastroenterol; 2023 Dec; 58(12):1261-1271. PubMed ID: 37676492
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study.
Vadhan-Raj S; McNamara MG; Venerito M; Riess H; O'Reilly EM; Overman MJ; Zhou X; Vijapurkar U; Kaul S; Wildgoose P; Khorana AA
Cancer Med; 2020 Sep; 9(17):6196-6204. PubMed ID: 32663379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
